The full content of Annals is available to subscribers

Subscribe/Learn More  >
Abstracts |

Effect of Dietary Calcium and Phosphorus on Toxicity of Lead in the Rat: Rationale of Phosphate Therapy.

[+] Article, Author, and Disclosure Information

By SHELLING DAVID H.. , (Proc. Soc. Exp. Biol. and Med.. , 1932; , xxx:, 248.-254.)

Ann Intern Med. 1933;6(7):962. doi:10.7326/0003-4819-6-7-962
Text Size: A A A
This excerpt has been provided in the absence of an abstract.

The rationale of the use of calcium compounds in the treatment of lead poisoning depended upon the following facts: First, the solubility of lead phosphate was found to be analogous to that of calcium phosphate; hence it was believed that lead might be deposited in bones in the same manner that lime salts are. Second, it was believed that the deposition of lead in the bones could be increased by furthering the process of calcification through the administration of calcium. Third, the prompt relief of lead colic through the intravenous administration of calcium chloride was thought to add additional evidence


First Page Preview

View Large
First page PDF preview





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Hyperphosphataemia and treatment with sevelamer in haemodialysis patients. Nephrol Dial Transplant 2003;18 Suppl 5():v47-9.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.